230 related articles for article (PubMed ID: 17311704)
1. Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.
Sapp CM; DeSimone P
Clin Colorectal Cancer; 2007 Jan; 6(5):382-5. PubMed ID: 17311704
[TBL] [Abstract][Full Text] [Related]
2. Genital erythrodysesthesia as a severe manifestation of capecitabine therapy: a report of 3 cases.
Fleta-Asín B; Alcántara-González J; Alonso-Castro L; Truchuelo-Díez M; Jaén-Olasolo P
Arch Dermatol; 2011 Sep; 147(9):1123-4. PubMed ID: 21931065
[No Abstract] [Full Text] [Related]
3. Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine?
Jeung HC; Chung HC
Asia Pac J Clin Oncol; 2010 Sep; 6(3):141-3. PubMed ID: 20887492
[No Abstract] [Full Text] [Related]
4. Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia.
Chalermchai T; Tantiphlachiva K; Suwanrusme H; Voravud N; Sriuranpong V
Asia Pac J Clin Oncol; 2010 Sep; 6(3):155-60. PubMed ID: 20887495
[TBL] [Abstract][Full Text] [Related]
5. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series.
Adames A; O'Brien DR; Kelly AR; Saltz LB; Garcia-Aguilar J; Zinovoy M; Williams V; Wu A; Reyngold M; Hajj C; Crane C; Cercek A; Smith JJ; Markova A; Cuaron J; McCann P; Romesser PB
Int J Colorectal Dis; 2024 May; 39(1):75. PubMed ID: 38780794
[TBL] [Abstract][Full Text] [Related]
6. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
[No Abstract] [Full Text] [Related]
7. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
Kara IO; Sahin B; Erkisi M
Breast; 2006 Jun; 15(3):414-24. PubMed ID: 16188440
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases.
Duman BB; Paydas S; Tetiker T; Gunaldı M; Afsar CU; Erçolak V; Haksöyler V; Dilli MŞ
Pharmacology; 2012; 90(3-4):212-5. PubMed ID: 23038659
[TBL] [Abstract][Full Text] [Related]
9. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
[TBL] [Abstract][Full Text] [Related]
10. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Kurt M; Babaoglu MO; Yasar U; Shorbagi A; Guler N
Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007
[TBL] [Abstract][Full Text] [Related]
12. [Myocardial ischaemia as a result of treatment with capecitabine].
van Halteren HK; Liem AH; Planting AS
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1469-73. PubMed ID: 17633978
[TBL] [Abstract][Full Text] [Related]
13. Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature.
Hennessy BT; Gauthier AM; Michaud LB; Hortobagyi G; Valero V
Ann Oncol; 2005 Aug; 16(8):1289-96. PubMed ID: 15890665
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
15. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
16. A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
Caronia D; Martin M; Sastre J; de la Torre J; García-Sáenz JA; Alonso MR; Moreno LT; Pita G; Díaz-Rubio E; Benítez J; González-Neira A
Clin Cancer Res; 2011 Apr; 17(7):2006-13. PubMed ID: 21325291
[TBL] [Abstract][Full Text] [Related]
17. Severe palmar-plantar erytrodysesthesia after treatment with capecitabine.
López V; Martín JM; Jordá E
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):106-8. PubMed ID: 19614859
[No Abstract] [Full Text] [Related]
18. Acute myeloid leukaemia secondary to treatment with capecitabine for metastatic colorectal cancer.
Shapiro S; Hughes G; Al-Obaidi MJ; O'Reilly E; Ramesh S; Smith J; Ahmad R; Dawson C; Riddle P; Sekhar M
Eur J Haematol; 2007 Jun; 78(6):543-4. PubMed ID: 17509107
[TBL] [Abstract][Full Text] [Related]
19. Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report.
Fantini M; Gianni L; Tassinari D; Nicoletti S; Possenti C; Drudi F; Sintini M; Bagli L; Tamburini E; Ravaioli A
J Oncol Pharm Pract; 2011 Sep; 17(3):288-91. PubMed ID: 20926454
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine-induced hypertriglyceridemia: a report of two cases.
Koutras AK; Habeos IG; Vagenakis AG; Kalofonos HP
Anticancer Res; 2006; 26(3B):2249-51. PubMed ID: 16821596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
